19.01.2012 08:35 Uhr, Quelle: Wallstreet online

DGAP-News: 4SC AG: Cancer compound resminostat meets primary endpoint in Phase II trial in advanced liver cancer ahead of schedule

DGAP-News: 4SC AG / Key word(s): Miscellaneous4SC AG: Cancer compound resminostat meets primary endpoint in Phase IItrial in advanced liver cancer ahead of schedule19.01.2012 / 08:254SC´s cancer compound resminostat meets primary endpoint in Phase …

Weiterlesen bei Wallstreet online

Digg del.icio.us Facebook email MySpace Technorati Twitter

JustMac.info © Thomas Lohner - Impressum - Datenschutz